MH MONOGRAM HEALTH KIDNEY ECONOMICS & ANALYTICS
Live / Applied — Fourth extension granted (statement of use) (as of 16 Jul 2025)
What this means for you
Not registered yet, but its 24 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97425709
- Mark type
- Design + words
- Filed
- 24 May 2022
- Published for opposition
- 23 May 2023
- Attorney of record
- Elisabeth A. Evert
Goods and services
- Class 035 — Advertising and business services: Business management services, including population health management services, for healthcare providers, programs, networks, and insurers in the field of chronic health condition care management and medical coordination; business management services, including population health management services, namely, administration of business program that supports efforts of healthcare providers, programs, networks, and insurers to improve patient health outcomes and cost of care; providing business, administrative and coordination/management services to healthcare providers, programs, networks, and insurers, namely, medical cost management, and medical practice management for others, all to improve patient health outcomes and cost of care, all of the foregoing in connection with the diagnosis and treatment of renal disease and/or the provision of renal benefit management services, including the treatment and management of conditions that are co-morbid with renal disease, namely, cardiovascular disease, hypertension, lung disease, or neurological disease; none of the foregoing including the provision of medical or diagnostic testing services, or the development of diagnostic tests, to determine the drug sensitivity and drug resistance of others for diagnostic or treatment purposes
- Class 042 — Scientific and technological services: Providing technology services, namely, scientific research, analysis, testing, and design in the field of artificial intelligence predictive analytics for the purpose of identifying patients for enrollment into care management programs, all of the foregoing in connection with the diagnosis and treatment of renal disease and/or the provision of renal benefit management services, including the treatment and management of conditions that are co-morbid with renal disease, namely, cardiovascular disease, hypertension, lung disease, or neurological disease; none of the foregoing including the provision of medical or diagnostic testing services, or the development of diagnostic tests, to determine the drug sensitivity and drug resistance of others for diagnostic or treatment purposes
Owner
- Monogram Health, Inc., Brentwood, TN, US
- Monogram Health, Inc., Brentwood, TN, US
Prior registrations
Prosecution history
- 19 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2025 — SOU EXTENSION 4 GRANTED
- 16 Jul 2025 — SOU EXTENSION 4 FILED
- 16 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2025 — SOU EXTENSION 3 GRANTED
- 15 Jan 2025 — SOU EXTENSION 3 FILED
- 27 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2024 — SOU EXTENSION 2 GRANTED
- 18 Jul 2024 — SOU EXTENSION 2 FILED